FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

VENUSREM Share Price Discussion

Venus Remedies Ltd.
Sector: Pharmaceuticals and health care
... Read more
VENUSREM Share Price *
25.95 +0 (0%)
* (quote may be delayed)

Find answers to all your questions on live VENUSREM message board: Is VENUSREM buy or sell? Should I buy VENUSREM shares? Why are VENUSREM shares falling? Should I invest in VENUSREM stock?


VENUSREM Discussion Forum

FAL Corp sells entire stake in ICICI Lombard; Axis Trustee offloads 12.93 lakh shares of Rel Cap
SK Growth Fund acquired 2,45,459 shares of newly listed Vishwaraj Sugar Industries at Rs 60.35 per share.
Moneycontrol
Like
reply
Reply
share
Share
  • VENUSREM - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization40.91
    Enterprise Value379.37
    Price to Earnings25.4
    Price to Book Value0.12
    Return on Capital Employed0.02
    Return on Equity-0.07
    Face Value10
    Dividend YieldNA
  • VENUSREM Share Price - Technicals

    keyboard_arrow_down
    VENUSREM - 52 Week High₹68
    VENUSREM - 52 Week Low₹18.8
  • VENUSREM Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Oct 2426.629.125.1525.95
    Oct 2329.8529.8527.8527.85
    Oct 2233.733.730.930.9
    Oct 1833.8535.330.9534.3
    Oct 1727.831.227.429.5
  • VENUSREM Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹24.06
    30 Day Moving Average₹23.87
    50 Day Moving Average₹23.61
    100 Day Moving Average₹24.36
    200 Day Moving Average₹29.74
  • VENUSREM - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue355375.45-0.05
    Operating Profit4375.04-0.43
    Profit Before Tax-231.05-22.9
    Net Income-274.75-6.68
  • VENUSREM - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds341368-0.07
    Total Liabilities3913800.03
    Total Assets732749-0.02
  • VENUSREM - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity52102.56-0.49
    Cash from Investing Activity-11-45.87-0.76
    Cash from Financing Activity-40-56.58-0.29
    Net Cash FlowNA0.11-1
  • VENUSREM - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.040.01
    Return on Equity-0.070.01
    Return on Capital Employed0.020.05
  • VENUSREM - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.21
    3 Year CAGR Growth in Operating Profit-0.51
    3 Year CAGR Growth in EBIDTA-0.5
    3 Year CAGR Growth in Net Income-6.93
    3 Yr CAGR Growth - Diluted EPS-6.48
  • VENUSREM - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.23
    5 Year CAGR Growth in Operating Profit-0.64
    5 Year CAGR Growth in EBIDTA-0.63
    5 Year CAGR Growth in Net Income-1.47
    3 Yr CAGR Growth - Diluted EPS-1.4
  • VENUSREM - Recent News

    keyboard_arrow_down
    NewsBot
    Oct 17 2:03 AM
    FAL Corp sells entire stake in ICICI Lombard; Axis Trustee offloads 12.93 lakh shares of Rel Cap
    Moneycontrol
    NewsBot
    Feb 18 4:57 PM
    NewsBot
    Nov 16 4:17 PM
    NewsBot
    Nov 15 5:52 PM
  • VENUSREM - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.